DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

Sangamo Biosciences, Inc. (NASDAQ: SGMO)

7.57 -0.29 (-3.63%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGMO $7.57 -3.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.62
Previous Close $7.85
Daily Range $7.54 - $7.88
52-Week Range $6.65 - $19.25
Market Cap $528.5M
P/E Ratio -18.69
Dividend (Yield) $0.00 (0.0%)
Volume 1,515,328
Average Daily Volume 985,582
Current FY EPS -$0.61




Drug Makers

Sangamo Biosciences, Inc. (SGMO) Description

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes. Website:

News & Commentary

Sangamo Biosciences Shares Tumbled 17% In July

Sangamo Biosciences could revolutionize patient care, but its shares come with big time risk.

Thursday's ETF Movers: GDX, XBI

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Sangamo Biosciences' (SGMO) CEO Edward Lanphier Discusses Q2 2015 Results - Earnings Call Transcript

Sangamo BioSciences (SGMO) Is Today's Strong On High Volume Stock

Sangamo BioSciences (SGMO) Stock: Weak On High Volume Today

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Wednesday's After-Hours Movers: Five Below, FireEye And More

MKM Partners' 4 Health Care Stocks to Sell Before June

Following Hepatitis C, This Could Be the Next Disease Researchers Cure

With an effective cure for hepatitis C now in place after decades of research, we asked three of our top healthcare analysts which disease they believed researchers may cross off the list next. Here's what they had to say.

See More SGMO News...

SGMO's Top Competitors

SGMO $7.57 (-3.63%)
Current stock: SGMO
AMGN $151.78 (-2.64%)
Current stock: AMGN
GILD $105.07 (-2.51%)
Current stock: GILD
BIIB $297.30 (-2.10%)
Current stock: BIIB